PT1427436E - Utilização de apoproteínas do soro do leite na profilaxia ou tratamento de infecção microbiana ou viral - Google Patents

Utilização de apoproteínas do soro do leite na profilaxia ou tratamento de infecção microbiana ou viral Download PDF

Info

Publication number
PT1427436E
PT1427436E PT02796345T PT02796345T PT1427436E PT 1427436 E PT1427436 E PT 1427436E PT 02796345 T PT02796345 T PT 02796345T PT 02796345 T PT02796345 T PT 02796345T PT 1427436 E PT1427436 E PT 1427436E
Authority
PT
Portugal
Prior art keywords
mixture
viral infection
microbial
prophylaxis
treatment
Prior art date
Application number
PT02796345T
Other languages
English (en)
Inventor
Michael Anthony Folan
Damien Brady
Original Assignee
Westgate Biolog Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Westgate Biolog Ltd filed Critical Westgate Biolog Ltd
Publication of PT1427436E publication Critical patent/PT1427436E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018Hydrolysed proteins; Derivatives thereof from animals from milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
PT02796345T 2001-08-23 2002-08-20 Utilização de apoproteínas do soro do leite na profilaxia ou tratamento de infecção microbiana ou viral PT1427436E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IES20010780 2001-08-23

Publications (1)

Publication Number Publication Date
PT1427436E true PT1427436E (pt) 2008-09-08

Family

ID=11042830

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02796345T PT1427436E (pt) 2001-08-23 2002-08-20 Utilização de apoproteínas do soro do leite na profilaxia ou tratamento de infecção microbiana ou viral

Country Status (15)

Country Link
US (2) US7687074B2 (pt)
EP (1) EP1427436B1 (pt)
JP (1) JP4532900B2 (pt)
KR (1) KR100907959B1 (pt)
CN (1) CN1578670B (pt)
AT (1) ATE399562T1 (pt)
AU (1) AU2002356112B2 (pt)
CA (1) CA2458146C (pt)
DE (1) DE60227389D1 (pt)
DK (1) DK1427436T3 (pt)
ES (1) ES2309228T3 (pt)
NZ (1) NZ531639A (pt)
PT (1) PT1427436E (pt)
RU (1) RU2305547C2 (pt)
WO (1) WO2003018049A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2863168A1 (fr) * 2003-12-04 2005-06-10 Centre Nat Rech Scient Utilisation d'inducteurs de la voie de degradation de la gamma-butyrolactone pour inactiver le signal n-acy homoserine lactone.
RU2007103835A (ru) * 2004-07-01 2008-08-10 Шепенс Ай Рисерч (Us) Композиции и способы лечения заболеваний и нарушений состояния глаз
CA2623483A1 (en) * 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
AU2006318655B2 (en) * 2005-11-18 2013-03-28 Glanbia Nutritionals (Ireland) Ltd. Compositions for disrupting and inhibiting reconstitution of wound biofilm
JP5017531B2 (ja) * 2006-09-11 2012-09-05 株式会社アップウェル 口内清浄剤
JP2011505415A (ja) * 2007-12-04 2011-02-24 ウエストゲート・バイオロジカル・リミテッド 遊離脂肪酸のブレンド及びその使用
JP2009190994A (ja) * 2008-02-13 2009-08-27 Kitasato Institute 抗インフルエンザウイルス剤、及びその有効成分の製造方法
KR101274543B1 (ko) * 2008-06-11 2013-06-17 리콤 코포레이션 인간 아드레날린 β3 수용체 리간드, 이를 포함하는 식품 및 의약품
US20090311236A1 (en) * 2008-06-11 2009-12-17 Immune @Work, Inc. Therapeutic Peptide Compositions And Methods Of Making And Using Same
US8808345B2 (en) * 2008-12-31 2014-08-19 Medtronic Ardian Luxembourg S.A.R.L. Handle assemblies for intravascular treatment devices and associated systems and methods
WO2010082587A1 (ja) * 2009-01-13 2010-07-22 株式会社大気倶楽部 空中懸濁物吸着剤
KR101119538B1 (ko) * 2009-06-10 2012-02-22 장선호 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방 및 치료용 조성물
ES2643862T3 (es) 2009-11-17 2017-11-24 Michael Anthony Folan Composiciones antimicrobianas que contienen ácidos grasos libres
AR082943A1 (es) * 2010-08-06 2013-01-23 Aptalis Pharma Ltd Formula nutricional predigerida
KR101355018B1 (ko) * 2010-12-13 2014-01-24 노부오 구보 시알릭산-함유 유청 단백질을 유효성분으로 함유하는 인플루엔자 바이러스 감염증의 예방용 동물사료 첨가제 및 이를 포함하는 동물사료용 조성물
RU2494726C2 (ru) * 2011-04-11 2013-10-10 Общество с Ограниченной Ответственностью "Производственная Торговая Компания "Лактив" Способ профилактики и лечения грибковой инфекции у больных с голосовыми протезами
EP3150257A1 (en) * 2015-09-30 2017-04-05 Buga, Doris A method for producing a composition for strengthening the immune system
CA3026402A1 (en) 2017-12-05 2019-06-05 James F. Kane Water-soluble cannabinoids and methods of making same
US11298379B2 (en) * 2020-04-16 2022-04-12 James F. Kane Compositions comprising milk fat globules and methods of making same

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2796378A (en) * 1954-04-09 1957-06-18 Jr Edgar A Ferguson Methionine free reaction product of a water-soluble copper salt and lactalbumin hydrolysate as fungicide
GB1050756A (pt) * 1964-09-10 1900-01-01
US4397927A (en) * 1982-03-25 1983-08-09 Brog Roy A Imitation milk compositions and aqueous dispersions prepared therefrom
US4918008A (en) * 1985-01-18 1990-04-17 Gauri Kailash Kumar Process for the preparation of protein hydrolysate and medicaments containing these hydrolysates
JPS62249931A (ja) * 1986-04-21 1987-10-30 Morinaga Milk Ind Co Ltd 抗菌性組成物
JPH085798B2 (ja) * 1987-02-02 1996-01-24 紀夫 多田 抗菌剤
ES2043279T3 (es) * 1989-06-07 1993-12-16 Kao Corp Emulsion comestible de aceite en agua.
JP2673320B2 (ja) 1990-01-25 1997-11-05 雪印乳業株式会社 う蝕原菌付着阻止剤
JPH04159232A (ja) * 1990-08-21 1992-06-02 Yakult Honsha Co Ltd 日和見感染症予防・治療用経口組成物
CA2094570A1 (en) 1992-05-27 1993-11-28 Jerome F. Trumbetas Enzymatic protein process and product
CA2148261A1 (en) 1992-10-30 1994-05-11 Jerry A. Peterson Anti-diarrheic product and method of treating rotavirus-associated infection
US5785984A (en) * 1993-02-05 1998-07-28 Kao Corporation Taste-modifying method and bitterness-decreasing method
US6197356B1 (en) * 1993-08-03 2001-03-06 Immunopath Profile, Inc. Process for preparing hypoallergenic foods
JP3694319B2 (ja) * 1994-08-16 2005-09-14 サバルワル,ヘマント 多量体アルファ−ラクトアルブミンを含有する抗菌組成物
JP4233615B2 (ja) * 1996-08-22 2009-03-04 森永乳業株式会社 経口抗ヒト爪白癬及び/又は爪白癬以外のヒト足部白癬用医薬品
DK0955058T3 (da) * 1997-01-09 2004-08-30 Morinaga Milk Industry Co Ltd Lactoferrintabletter
IE970541A1 (en) 1997-07-25 1999-01-27 Michael Anthony Folan Maternal immune secretions and their use in the treatment and/or prophylaxis of the buccal cavity
JP4129566B2 (ja) * 1997-09-05 2008-08-06 大塚製薬株式会社 肝臓脂肪蓄積抑制組成物及び肝臓脂肪蓄積抑制用食品添加剤
US6287590B1 (en) * 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
AUPP051497A0 (en) 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
CA2332127A1 (en) 1998-06-26 2000-01-06 N.V. Nutricia Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
GB9903584D0 (en) 1999-02-18 1999-04-07 Univ Leeds Modified calycins
JP3662445B2 (ja) * 1999-06-30 2005-06-22 花王株式会社 油中水型乳化油脂組成物
US7169416B2 (en) * 2001-05-23 2007-01-30 Nutricopia, Inc. Nutritional frozen dessert and methods of manufacture
US20030165606A1 (en) 2001-07-18 2003-09-04 Lasekan John B. Anti-regurgitation formula and uses thereof
EP1319407A1 (en) * 2001-12-14 2003-06-18 Montoie Import-Export S.A. Pharmaceutical composition for topical treatment of skin disorders and skin wounds

Also Published As

Publication number Publication date
EP1427436A2 (en) 2004-06-16
RU2305547C2 (ru) 2007-09-10
ES2309228T3 (es) 2008-12-16
RU2004108040A (ru) 2005-09-27
JP2005501863A (ja) 2005-01-20
US7687074B2 (en) 2010-03-30
US20100209526A1 (en) 2010-08-19
ATE399562T1 (de) 2008-07-15
AU2002356112B2 (en) 2007-11-08
JP4532900B2 (ja) 2010-08-25
EP1427436B1 (en) 2008-07-02
CA2458146A1 (en) 2003-03-06
DK1427436T3 (da) 2008-10-13
WO2003018049A3 (en) 2003-11-06
US20050042299A1 (en) 2005-02-24
US7972629B2 (en) 2011-07-05
CN1578670A (zh) 2005-02-09
DE60227389D1 (de) 2008-08-14
WO2003018049A2 (en) 2003-03-06
KR100907959B1 (ko) 2009-07-16
CN1578670B (zh) 2013-09-04
CA2458146C (en) 2012-07-24
KR20040041579A (ko) 2004-05-17
NZ531639A (en) 2006-02-24

Similar Documents

Publication Publication Date Title
PT1427436E (pt) Utilização de apoproteínas do soro do leite na profilaxia ou tratamento de infecção microbiana ou viral
KR101501790B1 (ko) 감염성 피부 및 점막 질환 치료약
US20100144618A1 (en) Compositions containing an intestinal trefoil peptide and a mucoadhesive
IL139231A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
MXPA03000353A (es) Medicamentos para tratamiento quimioterapeutico de enfermedades.
PT914110E (pt) Metodo de modulacao da micro-circulacao
US7538082B2 (en) Methods and compositions for treating oral and esophageal lesions
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
HUP0401672A2 (hu) Kis koncentrációjú peroxid alkalmazása hüvelyi fertőzések gyógyító vagy megelőző kezelésénél
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
WO2014205159A1 (en) Poloxamer based inhalation composition
WO2000016786A3 (en) Oxihumic acid and its use in the treatment of various conditions
WO2008088987B1 (en) Treatment of pain with naloxone
Hamad Minocycline superior to chloroquine phosphate as COVID-19 treatment
CN114712355B (zh) Rhps4在制备抑制金黄色葡萄球菌和铜绿假单胞菌药物中的应用
JP2004529095A (ja) 抗菌性ib−367ペプチドの経口投与による人工呼吸器関連性肺炎の予防法
NZ587372A (en) Treatment of bacterial, protozoan infections and cancer with a mixture of at least three different human interferon alpha proteins
Bawaskar et al. Aphasia in a farmer after viper bite
RU1782597C (ru) Способ профилактики некроза кожного лоскута на питательной ножке
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use
YU66099A (sh) Transdermalni sistem za davanje lekova i upotreba terapeutskih smeša u proizvodnji lekova za lečenje virusnih i mikrobskih infekcija i štetnih sindroma
WO2013053881A1 (en) Inhibitor of colonisation of mucosa
WO2003080110A1 (es) Liquido topico destructor de tejido patogeno
JP2001187746A (ja) 壊死性感染症の治療